Skip to Content

Notice

Electronic Investigational New Drug Application: Cumulative Table of Contents; Public Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice of public meeting.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a public meeting to discuss the possibility of using extensible markup language (XML) to create a cumulative table of contents for investigational new drug applications (IND's) intended to be submitted electronically to the Center for Biologics Evaluation and Research (CBER) or the Center for Drug Evaluation and Research (CDER). Although the agency does not yet have a comprehensive approach to accepting IND's in electronic format in place of paper, it is updating existing guidance to make electronically submitted IND's in place of paper possible in the future. The agency is hoping to gain public input at the meeting on the use of XML to create a cumulative table of contents.

DATES:

The public meeting will be held on January 26, 2001, from 8 a.m. to 4 p.m. Submit registration request by January 17, 2001. Written comments on the use of XML to create a cumulative table of contents are welcome at any time.

ADDRESSES:

The public meeting will be held in the CDER Advisory Committee Conference Room, 5630 Fishers Lane, rm. 1066, Rockville, MD 20852.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Randy Levin, Center for Drug Evaluation and Research (HFD-001), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-594-5400, e-mail: levinr@cder.fda.gov, or Robert A. Yetter, Center for Biologics Evaluation and Research (HFM-025), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0373, e-mail: yetter@cber.fda.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

FDA is holding a public meeting to discuss the possibility of using XML to create a cumulative table of contents for IND's intended to be submitted electronically to CBER or CDER. The agency is updating guidance to make electronically submitted IND's in place of paper possible in the future. The agency is interested in input from the public on the following questions related to the use of XML to create a cumulative table of contents:

  • Would a cumulative table of contents offer you advantages?
  • How difficult is it for you to create and maintain the XML files needed for the cumulative table of contents?
  • How difficult will it be for you to incorporate the preparation of an XML document in your submission preparation process?
  • Do you have suggestions for improvements on the cumulative table of contents?
  • Are you interested in piloting the cumulative table of contents in electronic IND's with the agency?
  • Are you interested in working with us to develop tools to be used with the cumulative table of contents?
  • Do you have other comments or suggestions?

An agenda and other materials including an example of a cumulative table of contents will be available prior to the meeting on the Internet at http://www.fda.gov/​cder/​regulatory/​ersr/​default.htm. Although there is no fee, preregistration by January 17, 2001, is required for all attendees at this meeting. Participation is limited to the first 100 registrants. To accommodate the greatest number of interested parties, registration is limited to persons outside FDA, and no more than two persons from an individual company should attend. Persons interested in attending the meeting should register by sending the names of those attending with the name of their company in an e-mail message to embreyj@cder.fda.gov.

The location of the meeting is 5630 Fishers Lane, next to the Parklawn Bldg. Please use the lower entrance, which faces Parklawn Dr. Visitor badges will be held at the guard station at the entrance to the building. Participants will need picture identifications to pick up their badge. Public parking is not available at the 5630 Fishers Lane location. A public parking lot is available on Fishers Lane across from the Parklawn Bldg., and additional public parking is available at the Start Printed Page 83070Twinbrook Metro Station located several blocks west of the meeting location.

Interested persons may submit to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, written comments on the use of XML to create a cumulative table of contents. Two copies of any comments are to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Comments are available for public examination in the Dockets Management Branch between 9 a.m. and 4 p.m., Monday through Friday.

Start Signature

Dated: December 22, 2000.

Margaret M. Dotzel,

Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 00-33370 Filed 12-28-00; 8:45 am]

BILLING CODE 4160-01-F